Nutritional supplement for significantly improving human health and method and application

Abstract

The invention discloses a nutritional supplement for significantly improving human health and a method and an application. The supplement includes Baoyuan decoction including the following raw materials by weight: 50-60 parts of konjak, 15-25 parts of turmeric, 20-30 parts of lycium ruthenicum, 25-35 parts of fekete ribizli, 5-15 parts of silybum marianum, 0.5-1 part of water and enteric fiber powder; clear mushroom including the following raw materials by weight: 10-20 parts of plant enzyme, 2-8 parts of barley powder, 7-15 parts of bifidobacterium powder, 5-12 parts of lactic acid bacteria powder, 0.5-5 parts of citric acid, 1-10 parts of lactose, 0.05-0.2 part of vitamin C, 4-10 parts of oligosaccharides, lemonade and pear juice. The nutritional supplement can improve the human body immunity and improve physiological and metabolic indicators of the human body.

Description

technical field [0001] The invention belongs to the field of health management, and in particular relates to a nutritional supplement, method and application for significantly improving human health. Background technique [0002] Methods to reduce the risk of various chronic diseases such as cancer and diabetes, hyperlipidemia, and hypertension include: (1) Genetic intervention: such as using CRISPR-Cas9 genome editing technology to correct mutations in embryos, which has the advantage of reducing disease-causing gene mutations frequency, and even fundamentally correct the mutant gene to a wild-type gene; the disadvantage is that this type of technology is not yet mature, especially for homozygous mutations, embryo gene correction cannot be effectively performed, and there are also safety and ethical concerns ; (2) Drug intervention: use drugs that improve genome stability or target certain pathological indicators, such as TA65, statins, sirtuins, aspirin, etc. Pathological...

AI Technical Summary

Problems solved by technology

[0002] Methods to reduce the risk of various chronic diseases such as cancer and diabetes, hyperlipidemia, and hypertension include: (1) Genetic intervention: such as using CRISPR-Cas9 genome editing technology to correct mutations in embryos, which has the advantage of reducing disease-causing gene mutations frequency, and even fundamentally correct the mutant gene to a wild-type gene; the disadvantage is that this type of technology is not yet mature, especially for homozygous mutations, embryo gene correction cannot be effectively performed, and there are also safety and ethical concerns ; (2) Drug intervention: use drugs that improve genome stability or target certain pathological indicators, such as TA65, statins, sirtuins, aspirin, etc. Pathological indicators can improve, but cannot fully improve the overall health level, and the drugs themselves have some toxic side effects, such as statins can damage liver function to a certain extent; (3) surgery: such as breast cancer or colon cancer high-risk people Breast or colon resection, or partial gastrectomy for people whose BMI (Body Mass Index) is seriously exceeded, to reduce the risk of cancer and various chronic diseases caused by obesity. The main disadvantage of this organ removal is that the traumatic operation itself has Certain risks, and there is no guarantee that other organs will not develop cancer. For example, mastectomy for people with BRCA1 / 2 gene mutations does not reduce their risk of ovarian cancer.

Images